Focus on Diabetes Care

Back to articles

Updated guideline released on use of oral medications to manage type 2 diabetes


Metformin remains the initial treatment of choice for patients with type 2 diabetes, and if a second agent is needed, clinicians should consider adding a sulfonylurea, a thiazolidinedione, a sodium–glucose cotransporter-2 (SGLT-2) inhibitor, or a dipeptidyl peptidase-4 (DPP-4) inhibitor, according to an updated guideline released by the American College of Physicians (ACP).